STOCKHOLDERS EQUITY (Details Narrative) - USD ($)	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Shares, Issued	948,750
Issuance of common stock shares	1,101,231	791,667
Stock Options Granted During Period	8,700,000
Total share-based compensation expense	$ 245,384	$ 205,925
Sale shares of common stock	1,107,923
Weighted average price of shares issued	$ 2.20
Proceeds from issuance of common stock	$ 2,437,375
Issuance costs related to this sale	$ 45,058
Common Stock Warrants [Member]
Share-based compensation expense	948,750
Weighted average price of shares issued	$ 0.85
Proceeds from issuance of common stock	$ 806,438
General And Administrative Expense [Member]
Total share-based compensation expense	67,708	160,069
Salaries and Benefits Expenses [Member]
Total share-based compensation expense	173,776	$ 45,856
Professional fees [Member]
Total share-based compensation expense	$ 3,900
Options [Member]
Stock Options Granted During Period	470,000
Share-based compensation expense	322,500
Cashless exercise shares of common stock	46,269
Shares of common stock were issued	276,231
Intrinsic Value of Options Exercised	$ 475,533
Number of Options Exercised	322,500
Weighted Average Remaining Contractual Term	4 years 3 months 18 days
Unrecognized compensation expense	$ 1,121,058
Weighted-average remaining life	2 years
Restricted Stock Units [Member]
Weighted Average Remaining Contractual Term	1 year 6 months
Unrecognized compensation expense	$ 683,758
Weighted-average remaining life	2 years
Equity Incentive Plan [Member]
Stock Options Granted During Period	470,000
Restricted Stock Units Granted During Period	250,000
Minimum [Member] | Options [Member]
Weighted Average Remaining Contractual Term	3 years
Maximum [Member] | Options [Member]
Weighted Average Remaining Contractual Term	10 years